Karen Gallo-Willard

Brussels, BRU 1070, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Reinvigorating the Cancer-Immunity Cycle by Intratumoral Administration of Conventional Dendritic Cells in Melanoma and Other Solid Tumors: A Narrative Review.

Reinvigorating the Cancer-Immunity Cycle by Intratumoral Administration of Conventional Dendritic Cells in Melanoma and Other Solid Tumors: A Narrative Review.

Journal: Vaccines

Published: March 30, 2026

Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer.

Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer.

Journal: Frontiers in immunology

Published: February 23, 2026

Aspirin in Colorectal Cancer Care: Who to Treat, When, and Why.

Aspirin in Colorectal Cancer Care: Who to Treat, When, and Why.

Journal: Current oncology reports

Published: January 12, 2026

Spatial multiomics of the breast tumour microenvironment: State of the field, advancements and clinical implementation promises.

Spatial multiomics of the breast tumour microenvironment: State of the field, advancements and clinical implementation promises.

Journal: Critical reviews in oncology/hematology

Published: November 03, 2025

RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer.

RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer.

Journal: NPJ breast cancer

Published: July 31, 2025

The interplay between gut microbiota, antibiotics, and immune checkpoint inhibitors in patients with cancer: A narrative review with biological and clinical aspects.

The interplay between gut microbiota, antibiotics, and immune checkpoint inhibitors in patients with cancer: A narrative review with biological and clinical aspects.

Journal: Critical reviews in oncology/hematology

Published: April 05, 2025

Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study.

Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study.

Journal: Nature communications

Published: January 24, 2025

The interplay between the immune response and neoadjuvant therapy in breast cancer.

The interplay between the immune response and neoadjuvant therapy in breast cancer.

Journal: Frontiers in oncology

Published: September 12, 2024

Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy.

Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy.

Journal: British journal of cancer

Published: July 23, 2024

Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy.

Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy.

Journal: Expert review of clinical immunology

Published: July 15, 2024

Tumor-Infiltrating Lymphocyte Scoring in Neoadjuvant-Treated Breast Cancer.

Tumor-Infiltrating Lymphocyte Scoring in Neoadjuvant-Treated Breast Cancer.

Journal: Cancers

Published: July 10, 2024

Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma.

Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma.

Journal: Journal for immunotherapy of cancer

Published: December 13, 2023

Showing 1-12 of 83

Last Updated: 09/26/2026